Development and Validation of Q-Absorbance Ratio by UV-Spectrophotometric Method for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Combined Dosage Form
Abstract
Advantages of simultaneous stability studies are the identification of new degradation products, to understand mutual induction and/or inhibition of rates of degradation and to analyze the degradation products of both drugs. Various ultraviolet spectroscopic and high performance liquid chromatographic assay methods were reported for the estimation of metformin, sitagliptin, pioglitazone, glimepiride and simvastatin individually and in combination with other drugs. All the above reported methods were based on the estimation of metformin, sitagliptin, pioglitazone, glimepiride and simvastatin alone or in combination with other drugs. The degradation products were generated and successfully separated by the developed and validated high performance liquid chromatographic methods for the estimation of the selected anti-diabetic drug combinations. The aim of the study was to develop and validate of Q-Absorbance Ratio UV-Spectrophotometric Method for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Combined Dosage Form.
Keywords: Metformin, Method Development, Validation, Empagliflozin, UV-Spectrophotometer.
Keywords:
Metformin, Method Development, Validation, Empagliflozin, UV-SpectrophotometerDOI
https://doi.org/10.22270/jddt.v11i2-S.4624References
Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T. Involvement of b2-glycoprotein I and anti-cardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 1997; 107:569-73.
Dhaliya SA, Surya AS, Dawn VT, Betty C, Arun K, Sunil C. A review of hyperlipidemia and medicinal plants. IJAPS BMS 2013; 2:219-37.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 1997; 23:3-25.
Shelke S, Shahi S, Jadhav K, Dhamecha D, Tiwari R, Patil H. Thermoreversible nano-ethosomal gel for the intranasal delivery of Eletriptan hydrobromide. J Mater Sci Mater Med 2016; 27:1-3.
Shelke S, Shahi S, Jalalpure S, Dhamecha D. Poloxamer 407 based intranasal thermoreversible gel of zolmitriptanloaded nano liposomes: formulation, optimization, evaluation and permeation studies. J Liposome Res 2016; 26:313-23.
Gursoy RN, Benita S. Self-emulsifying drug delivery systems for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58:173-82.
Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care 2013; 40:195-211.
Rohilla A, Dagar N, Rohilla S, Dahiya A, Kushnoor A. Hyperlipidemia–a deadly pathological condition. Int J Curr Pharm Res 2012; 4:15-8.
Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112:432-7.
Rohilla AN, Dagar N, Rohilla S, Dahiya A, Kushnoor A. Hyperlipidemia a deadly pathological condition. Int J Curr Pharm Res 2012; 4:15-8.
Nakamura K, Miyoshi T, Yunoki K, Ito H. Postprandial hyperlipidemia as a potential residual risk factor. J Cardiol 2016; 67:335-9.
Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52:1544.
Published
Abstract Display: 909 
PDF Downloads: 955 PDF Downloads: 335 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.